Literature DB >> 2485288

The effects of varying cigarette deprivation duration on cognitive and performance tasks.

D Hatsukami1, L Fletcher, S Morgan, R Keenan, P Amble.   

Abstract

The effects of varying times of cigarette deprivation on cognitive and performance tasks were examined. This study employed a between-subjects design in which five groups of smokers (9-10 subjects in each group) were compared on a vigilance task and cognitive measures as a function of length of deprivation (0, 2, 4, 8, or 24 hours). Each subject was tested during baseline ad-lib smoking and at one of the deprivation durations. Difference scores were compared between the 0-hour group and the 2-, 4-, 8-, and 24-hour groups. The results showed that there were no significant withdrawal effects on the measures at 2, 4, and 8 hours after cigarette deprivation with the exception of poorer performance on the Trail Making Test (B) at 4 hours, However, there were significant withdrawal effects at 24-hours deprivation. These included increased mean reaction time, increased variability in reaction time, and increased errors of commission on the vigilance task. There were near significant changes at 24-hours deprivation on the Trail Making Test (B) and Symbol Digits Modalities.

Mesh:

Substances:

Year:  1989        PMID: 2485288

Source DB:  PubMed          Journal:  J Subst Abuse        ISSN: 0899-3289


  31 in total

Review 1.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

2.  The early time course of smoking withdrawal effects.

Authors:  Peter S Hendricks; Joseph W Ditre; David J Drobes; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

3.  Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence.

Authors:  Jiansong Xu; Adrianna Mendrek; Mark S Cohen; John Monterosso; Paul Rodriguez; Sara L Simon; Arthur Brody; Murray Jarvik; Catherine P Domier; Richard Olmstead; Monique Ernst; Edythe D London
Journal:  Biol Psychiatry       Date:  2005-07-15       Impact factor: 13.382

4.  A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning.

Authors:  Lynne Dawkins; Jane H Powell; Robert West; John Powell; Alan Pickering
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

5.  Severity of tobacco abstinence symptoms varies by time of day.

Authors:  Kenneth A Perkins; Jessica Briski; Carolyn Fonte; John Scott; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

Review 6.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

7.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

8.  Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a Stroop task.

Authors:  Allen Azizian; Liam J Nestor; Doris Payer; John R Monterosso; Arthur L Brody; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2009-11-11       Impact factor: 7.853

Review 9.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.

Authors:  Scott H Kollins; Joseph S English; Michelle E Roley; Benjamin O'Brien; Justin Blair; Scott D Lane; F Joseph McClernon
Journal:  Psychopharmacology (Berl)       Date:  2012-12-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.